Poster # 1024 Neo-Adjuvant Androgen Deprivation Therapy Does Not Increase the Risk of Cardiovascular Death in Men Treated for Prostate Cancer with Curative Intent

Presenter: Paul Blood, MD, PhD

About the Presenter:
Paul Blood is a radiation oncologist at the BC Cancer Agency in Victoria, British Columbia, Canada. He has a PhD in epidemiology. His research interests include prostate cancer outcomes using linked BC population data, and prostate cancer immunology in collaboration with the Deeley Research Centre in Victoria, BC.
Contact the presenter at:


E-mail a friend about this poster:
Enter email address: